Neurogene NGNE
NASDAQ NGNE
$26.55 -1.27 (-4.57%)
At close: Oct 1, 2026 · 4:00 PM EDT

Neurogene (NGNE) Long-Term Debt Repayments (2014 - 2026)

Updated

Neurogene (NGNE) recorded Long-Term Debt Repayments of $5,000 in Q2 2026, down 64.3% from $14,000 a year earlier and down 16.7% from the prior quarter.

Analysis

Neurogene (NGNE) Long-Term Debt Repayments (2014 - 2026) Analysis & Trends

On a TTM basis, Neurogene's Long-Term Debt Repayments came in at $43,000 as of Jun 30, 2026, down 20.4% year-over-year; for FY2025, it came in at $61,000, up 17.3% from FY2024.

  • Annual Long-Term Debt Repayments has a five-year compound annual growth rate of 4.5% (FY2020 to FY2025).
  • Across earlier years, Long-Term Debt Repayments came in at $52,000 in FY2024 (+79.3%), $29,000 in FY2023, $1,000 in FY2022 (-98.0%) and $51,000 in FY2021 (+4.1%).
  • Quarterly Long-Term Debt Repayments has ranged from -$53,000 in Q4 2022 to $52,000 in Q3 2022 over the past five years.
  • On a year-over-year basis, Long-Term Debt Repayments rose in five of the last eight quarters, with growth averaging 4.6%.
  • Peak year-over-year performance for Long-Term Debt Repayments in the last five years was growth of 500.0% in Q2 2023, against a decline of 80.8% in Q3 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $6,000 (Q1 2026), $19,000 (Q4 2025) and $13,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.00 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.45 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 17.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Neurogene 627.40 Mn 627.40 Mn - 5,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5,000.00
Mar 31, 2026 6,000.00
Dec 31, 2025 19,000.00
Sep 30, 2025 13,000.00
Jun 30, 2025 14,000.00
Mar 31, 2025 15,000.00
Dec 31, 2024 13,000.00
Sep 30, 2024 12,000.00
Jun 30, 2024 16,000.00
Mar 31, 2024 11,000.00
Dec 31, 2023 8,000.00
Sep 30, 2023 10,000.00
Jun 30, 2023 6,000.00
Mar 31, 2023 5,000.00
Dec 31, 2022 -53,000.00
Sep 30, 2022 52,000.00
Jun 30, 2022 1,000.00
Mar 31, 2022 1,000.00
Dec 31, 2021 49,000.00
Jun 30, 2021 2,000.00
API Access

Neurogene Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=NGNE&period=max&api_key=YOUR_API_KEY